British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot ...

GSK PLC, (OTC:GLAXF),has been noted by broker Berenberg, which highlights a potential easing of challenges that have impacted ...

Germany’s Stada is to expand its over-the-counter business after agreeing to buy a portfolio of consumer health products from GlaxoSmithKline. No financial details of the agreement have been ...

The data showed that a vaccine candidate produced positive immune responses against both A and B flu strains in younger and ...

GlaxoSmithKline is to buy out Novartis from their over-the-counter joint venture, and may sell its Horlicks business to fund the £9.2 billion ($13bn) acquisition.

GSK, one of the world's largest vaccine manufacturers, under CEO Emma Walmsley has focussed on vaccines and infectious diseases as a strategy to boost sales and counter patent expiries and ...

British drugmaker GSK announced on Thursday positive results from a mid-stage trial of its seasonal influenza vaccine ...

GSK hit with high-stakes setback in Zantac saga ... Sanofi acquired the then-over-the-counter treatment in a 2016 asset swap with Boehringer Ingelheim and then pulled Zantac off the market in ...

On Wednesday, a jury in Cook County Circuit Court in Illinois ended in a mistrial in a case against Zantac manufacturer ...

GSK bought partner CureVac out of their alliance on influenza and COVID-19 vaccine development, boosting its messenger RNA credentials.

Follow today’s news live. Biden caught on hot mic telling Albanese and other Quad leaders China 'testing us' 04:43 ...